Clinical Trial Update: Assessment of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple Subcutaneous Injections of GenSci120 in Healthy Adult Participants in China. [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial update assessing safety, tolerability, pharmacokinetics, and pharmacodynamics of multiple subcutaneous injections of GenSci120 in healt…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• GenSci120

Snippet

Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd. | Conditions: Rheumatoid Arthritis | Phase 1 | Status: RECRUITING